Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
Abstract Background Heterogeneity and lack of targeted therapies represent the two main impediments to precision treatment of triple-negative breast cancer (TNBC), and therefore, molecular subtyping and identification of therapeutic pathways are required to optimize medical care. The aim of the pres...
Main Authors: | Pascal Jézéquel, Olivier Kerdraon, Hubert Hondermarck, Catherine Guérin-Charbonnel, Hamza Lasla, Wilfried Gouraud, Jean-Luc Canon, Andrea Gombos, Florence Dalenc, Suzette Delaloge, Jérôme Lemonnier, Delphine Loussouarn, Véronique Verrièle, Mario Campone |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | Breast Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13058-019-1148-6 |
Similar Items
-
Immunomics in Pediatric Rheumatic Diseases
by: Shi Huan Tay, et al.
Published: (2019-05-01) -
Editorial: Immune system modeling and analysis
by: Ramit eMehr
Published: (2014-12-01) -
Tumor-Associated Tertiary Lymphoid Structures: From Basic and Clinical Knowledge to Therapeutic Manipulation
by: Charlotte Domblides, et al.
Published: (2021-06-01) -
Editorial: Immune Outposts on the Inflammatory Frontier: Tertiary Lymphoid Structures as Targets for Immunotherapy of Cancer and Autoimmunity
by: Karina Silina, et al.
Published: (2019-05-01) -
Systemic Sclerosis Perturbs the Architecture of the Immunome
by: Bhairav Paleja, et al.
Published: (2020-08-01)